The 2022 report on findings of the unlinked anonymous monitoring survey of HIV and viral hepatitis among people who inject drugs contains updates on hepatitis C prevalence, testing uptake and care & treatment.
HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England.
The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event.
We will be publishing a written summary of the other presentations from this event soon.
